State Street’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

State Street’s Portfolio ATXI Stock Details ATXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-408	Closed	-$4.51K	–	4407
2024 Q1	$4.51K	Hold	408	–	–	﹤0.01%	4353
2023 Q4	$4.97K	Hold	408	–	–	﹤0.01%	4425
2023 Q3	$21.5K	Hold	408	–	–	﹤0.01%	4433
2023 Q2	$35.2K	Hold	408	–	–	﹤0.01%	4500
2023 Q1	$35.8K	Buy	+408	New	+$37.7K	﹤0.01%	4585
2021 Q2	–	Sell	-128	Closed	-$873K	–	4492
2021 Q1	$873K	Buy	128 +35	+38%	+$240K	﹤0.01%	3651
2020 Q4	$622K	Buy	93 +28	+43%	+$147K	﹤0.01%	3625
2020 Q3	$794K	Buy	65 +5	+8%	+$60.8K	﹤0.01%	3497
2020 Q2	$721K	Buy	+60	New	+$677K	﹤0.01%	3488

Other funds holding ATXI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street's ATXI Position: Q2 2024 in Review

State Street sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q2 2024, closing a stake of 408 shares — an estimated $4.51K sold.

State Street first reported a position in ATXI in Q2 2020 and held it in 9 quarters. The position peaked at $873K in Q1 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

State Street reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
State Street sold 408 Avenue Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.51K.
State Street first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
State Street's Avenue Therapeutics, Inc. Common Stock position peaked at $873K in Q1 2021.
9 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.